PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer
| dc.contributor.author | McCubrey, James A. | |
| dc.date.accessioned | 2022-02-04T13:48:46Z | |
| dc.date.available | 2022-02-04T13:48:46Z | |
| dc.date.issued | 2017-02-21 | |
| dc.identifier.doi | 10.1038/srep43013 | |
| dc.identifier.issn | 2045-2322 | |
| dc.identifier.uri | http://hdl.handle.net/10342/9643 | |
| dc.language.iso | en_US | en_US |
| dc.subject | PTEN | en_US |
| dc.subject | MEK and mTOR inhibition | en_US |
| dc.subject | cancer | en_US |
| dc.title | PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer | en_US |
| dc.type | Article | en_US |
| ecu.journal.name | Scientific Reports | en_US |
| ecu.journal.pages | 43013 | en_US |
| ecu.journal.volume | 7 | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- McCubreyPTENStatusisaCrucialDeterminantoftheFunctionalOutcome.pdf
- Size:
- 2.22 MB
- Format:
- Adobe Portable Document Format
- Description:
- Article